Ausgabe 8/2021
Inhalt (11 Artikel)
Levofloxacin might be safe to use for OSCC patients
Levent Aydemir, Elif Sinem Iplik, Baris Ertugrul, Goksu Kasarci, Merve Nur Atas, Murat Ulusan, Arzu Ergen, Bedia Cakmakoglu
Upregulation of apoptotic protease activating factor-1 expression correlates with anti-tumor effect of taxane drug
Meysam Bakhshoudeh, Kayhan Mehdizadeh, Saman Hosseinkhani, Farangis Ataei
Analyzing the impact of ATF3 in tumorigenesis and immune cell infiltration of ovarian tumor: a bioinformatics study
Xiaoliu Li, Panpan Liu, Xiaona Sun, Runhong Ma, Ting Cui, Ting Wang, Yang Bai, Yuxia Li, Xiujuan Wu, Xianling Feng
Impact of a combined integrative oncology and palliative care program on quality of life of patients with advanced cancer
Eran Ben-Arye, Yonatan Yakubov, Noah Samuels, Orit Gressel, Alexander Yosipovich, Elad Schiff, Mattan Ophir, Walid Saliba, Jamal Dagash
Computational study on novel natural inhibitors targeting BCL2
Xiaye Lv, Yuting Jiang, Xinhui Wang, HaoQun Xie, Gaojing Dou, Jing Wang, Wenzhuo Yang, Hongyu Wang, Zijian Li, Xiangheng Zhang, Zhenghe Chen
ARA-linker-TGFαL3: a novel chimera protein to target breast cancer cells
Abdolamir Ghadaksaz, Abbas Ali Imani Fooladi, Hamideh Mahmoodzadeh Hosseini, Taher Nejad Satari, Mohsen Amin
PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer
Meghana Parsi, Milap H. Desai, Devashish Desai, Sachi Singhal, Pushti M. Khandwala, Rashmika R. Potdar
Vaccination of cancer patients against COVID-19: towards the end of a dilemma
Avik Mandal, Pritanjali Singh, Arghadip Samaddar, Dharmendra Singh, Manika Verma, Amrita Rakesh, Rakesh Ranjan
The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies
Yogita Chhichholiya, Prabhat Suman, Sandeep Singh, Anjana Munshi
Resveratrol effects in oral cancer cells: a comprehensive review
Tamires Cunha Almeida, Glenda Nicioli da Silva, Daniel Vitor de Souza, Andrea Cristina de Moraes Malinverni, Odair Aguiar Jr, Debora Estadella, Daniel Araki Ribeiro
Can the host immune response against SARS-CoV2 also cause an anticancer effect?
Seda Kahraman, Muhammed Bulent Akinci, Mehmet Ali Nahit Sendur, Bulent Yalcin